Marco Sardina

Title: Marco Sardina: Innovator in Pharmaceutical Compositions

Introduction

Marco Sardina is a notable inventor based in Gerenzano, Italy. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalation therapies for obstructive airway diseases.

Latest Patents

Marco Sardina holds 2 patents related to pharmaceutical compositions containing budesonide and formoterol. His inventions focus on inhalation formulations designed for the treatment of conditions such as asthma and chronic obstructive pulmonary disease (COPD). The first patent describes a pharmaceutical composition that includes a first powder of budesonide, leucine, and lactose, along with a second powder of formoterol, leucine, and lactose. This composition achieves a fine particle fraction (FPF) greater than 60% and a delivered fraction (DF) exceeding 80%. The second patent further refines this formulation, ensuring a fine particle fraction greater than 60% and a delivered fraction greater than 90%.

Career Highlights

Marco is currently associated with Zambon S.p.a., a company known for its commitment to innovative pharmaceutical solutions. His work has been instrumental in advancing inhalation therapies that improve patient outcomes in respiratory diseases.

Collaborations

Throughout his career, Marco has collaborated with talented professionals, including Loretta Maggi and Giovanni Caponetti. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical products.

Conclusion

Marco Sardina's contributions to pharmaceutical compositions highlight his dedication to improving treatments for obstructive airway diseases. His innovative work continues to impact the field positively.